COVID19

Ascletis Announces Positive Phase I Clinical Results of Oral RdRp Inhibitor ASC10 for COVID-19

Based on Ascletis' Phase I results of ASC10 and molnupiravir's clinical efficacy data in American, Japanese and Chinese patients, 800 mg twice daily of ASC...

 December 13, 2022 | News

China further optimizes COVID-19 response with new measures

Local authorities across China have soon made specific policies to implement the 10 new prevention and control measures recently rolled out by th...

 December 12, 2022 | News

Pictor announces funding round after successful launch in New Zealand and US of SARS-CoV-2 Antibody Test

 Pictor, a global leader in immunodiagnostics,  announced a funding round to help accelerate pipeline product development projects along with mar...

 December 05, 2022 | News

YS Biopharma Announces US FDA Clearance Of IND Application For PIKA COVID-19 vaccine

PIKA COVID-19 vaccine is composed of PIKA adjuvant and a stable trimeric form of the recombinant SARS-CoV-2 spike (S) protein as the main antigen component...

 November 11, 2022 | News

Merck Highlights New Data for Evobrutinib

Phase II clinical trial data of evobrutinib demonstrated low disease activity and stable EDSS, with NfL levels, a marker of neuronal injury, remaining lo...

 October 26, 2022 | News

SK bioscience and CEPI Sign Agreement to Develop mRNA Vaccines

  CEPI supports up to 40 mil. USD for early development of mRNA vaccine platform to SK bioscience; up to a further 100 mil. could be made available...

 October 26, 2022 | News

U.S. FDA Grants EUA for Novavax COVID-19 Vaccine, Adjuvanted as a Booster for Adults

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases,...

 October 24, 2022 | News

Novavax Prototype COVID-19 Vaccine Data Support Homologous and Heterologous Boosting and Suggest Benefit Against Variants

Study 307 (Lot Consistency) achieved its primary endpoint, showing that three vaccine lots induced a comparable immune response thereby demonstrating the...

 October 13, 2022 | News

Roche launches COVID-19 test that detects and differentiates the emerging variant of interest BA.2.75

Roche (SIX: RO, ROG;OTCQX: RHHBY) and its subsidiary TIB Molbiol have developed a  COVID-19 test for researchers that detects and differentiates ...

 August 22, 2022 | News

Seegene launches the world's first in-life PCR campaign in Vietnam

Seegene's in-life PCR campaign is a global initiative designed to encourage regular testing for respiratory viruses, including COVID-19, flu and ...

 August 17, 2022 | News

Vela Diagnostics Supports COVID-19 Surveillance Efforts in Kenya

The NPHL operates under Kenya's Ministry of Health and plays an important role in the nation's healthcare by providing reference testing for key ...

 August 04, 2022 | News

Persistent Loss of Smell Due to Covid-19 Closely Connected to Long-Lasting Cognitive Problems

Also, ICU Stay May Double Risk of Dementia in Older Adults  SAN DIEGO, Aug. 1, 2022 /PRNewswire/ -- New insights into factors that may...

 August 01, 2022 | News

Brii Biosciences Announces Positive Data Demonstrating its Long-Acting COVID-19 Neutralizing Antibody Therapy

Independent lab results demonstrate that the combination therapy retains neutralizing activity against currently dominant COVID-19 strains, as previously d...

 July 27, 2022 | News

Brii Bio Announces Strategic Partnership with China Resources Pharmaceutical Commercial Group

The partnership will accelerate stockpiling, channel distribution and hospital access for the amubarvimab/romlusevimab combination in China The ...

 July 20, 2022 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close